Publications

Delpoux A, Michelini RH, Verma S, Lai CY, Omilusik KD, Utzschneider DT, Redwood AJ, Goldrath AW, Benedict CA, Hedrick SM
Bitra A, Doukov T, Wang J, Picarda G, Benedict CA, Croft M, Zajonc DM
Swanson KV, Junkins RD, Kurkjian CJ, Holley-Guthrie E, Pendse AA, El Morabiti R, Petrucelli A, Barber GN, Benedict CA, Ting JP
Jackson SE, Redeker A, Arens R, van Baarle D, van den Berg SPH, Benedict CA, Čičin-Šain L, Hill AB, Wills MR
Dufour F, Rattier T, Shirley S, Picarda G, Constantinescu AA, Morlé A, Zakaria AB, Marcion G, Causse S, Szegezdi E, Zajonc DM, Seigneuric R, Guichard G, Gharbi T, Picaud F, Herlem G, Garrido C, Schneider P, Benedict CA, Micheau O
Aug 12, 2016

cGAS-STING signaling regulates initial innate control of cytomegalovirus infection

Lio CJ, McDonald B, Takahashi M, Dhanwani R, Sharma N, Huang J, Pham E, Benedict CA, Sharma S
Oct 1, 2015

Cytomeglaovirus-specific CD4 T cells are cytolytic and mediate vaccine protection

Verma S, Weiskopf D, Gupta A, McDonald B, Peters B, Sette A, Benedict CA
Sep 1, 2015

Cardif (MAVS) regulates the maturation of NK cells

Haynes LD, Verma S, McDonald B, Wu R, Tacke R,Nowyhed HN, Ekstein J, Feuvrier A, Benedict CA, Hedrick CC
Aug 1, 2014

Inhibition of the TRAIL death receptor by CMV reveals its importance in NK cell-mediated antiviral defense

Verma S, Loewendorf A, Wang Q, McDonald B, Redwood A, Benedict CA
Apr 1, 2014

Neutrophils recruited by IL-22 in peripheral tissues function as TRAIL-dependent antiviral effectors against MCMV

Stacey MA, Marsden M, Pham N TA, Clare S, Dolton G, Stack G, Jones E, Klenerman P, Gallimore AM, Taylor PR, Snelgrove RJ, Lawley TD, Dougan G, Benedict CA, Jones SA, Wilkinson GW, Humphreys IR
Apr 1, 2014

Distinct requirements of activation of NKT and NK cells during viral infection

Tyznik AJ, Verma S, Wang Q, Kronenberg M, Benedict CA
Nov 1, 2013

A CMV vaccine: TREATing despite the TRICKs

Benedict, CA